Roles of FGFs as paracrine or endocrine signals in liver development, health, and disease

Frontiers in Cell and Developmental Biology

Volumn 4, Issue APR, 2016, Pages

  Itoh, Nobuyuki ^a   Nakayama, Yoshiaki ^b   Konishi, Morichika ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Carcinoma; Development; Disease; FGF; Liver; Metabolism

Indexed keywords

EID: 85049506142     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2016.00030     Document Type: Review

References (74)

1. Adams, A. C., Yang, C., Coskun, T., Cheng, C. C., Gimeno, R. E., Luo, Y., et al. (2010). The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Mol. Metab. 2, 31-37. doi: 10.1016/j.molmet.2012.08.007
2. Antoine, M., Wirz, W., Tag, C. G., Gressner, A. M., Marvituna, M., Wycislo, M., et al. (2007). Expression and function of fibroblast growth factor (FGF) 9 in hepatic stellate cells and its role in toxic liver injury. Biochem. Biophys. Res. Commun. 361, 335-341. doi: 10.1016/j.bbrc.2007.06.189
3. Baird, A., and Klagsbrun, M. (1991). The fibroblast growth factor family. Cancer Cells 3, 239-243
4. Beenken, A., and Mohammadi, M. (2012). The structural biology of the FGF19 subfamily. Adv. Exp. Med. Biol. 728, 1-24. doi: 10.1007/978-1-4614-0887-1_1
5. Berg, T., Rountree, C. B., Lee, L., Estrada, J., Sala, F. G., Choe, A., et al. (2007). Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation. Hepatology 46, 1187-1197. doi: 10.1002/hep.21814
6. Bhatia, S. N., Underhill, G. H., Zaret, K. S., and Fox, I. J. (2014). Cell and tissue engineering for liver disease. Sci. Transl. Med. 6, 245sr2. doi: 10.1126/scitranslmed.3005975
7. Burgess, W. H., and Maciag, T. (1989). The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575-606. doi: 10.1146/annurev.bi.58.070189.003043
8. Calmont, A., Wandzioch, E., Tremblay, K. D., Minowada, G., Kaestner, K. H., Martin, G. R., et al. (2006). An FGF response pathway that mediates hepatic gene induction in embryonic endoderm cells. Dev. Cell 11, 339-348. doi: 10.1016/j.devcel.2006.06.015
9. Cheng, X., Vispute, S. G., Liu, J., Cheng, C., Kharitonenkov, A., and Klaassen, C. D. (2014). Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR). Toxicol. Appl. Pharmacol. 278, 65-71. doi: 10.1016/j.taap.2014.04.013
10. Choi, M., Moschetta, A., Bookout, A. L., Peng, L., Umetani, M., Holmstrom, S. R., et al. (2006). Identification of a hormonal basis for gallbladder filling. Nat. Med. 12, 1253-12555. doi: 10.1038/nm1501
11. Colvin, J. S., White, A. C., Pratt, S. J., and Ornitz, D. M. (2001). Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128, 2095-2106
12. Crossley, P. H., and Martin, G. R. (1995). The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121, 439-451
13. Demir, M., Lang, S., and Steffen, H. M. (2015). Nonalcoholic fatty liver disease: current status and future directions. J. Dig. Dis. 16, 541-557. doi: 10.1111/1751-2980.12291
14. Doycheva, I., and Loomba, R. (2014). Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD). Adv. Ther. 31, 30-43. doi: 10.1007/s12325-013-0084-6
15. Fang, F., Chang, R. M., Yu, L., Lei, X., Xiao, S., Yang, H., et al. (2015). MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. J. Hepatol. 63, 874-885. doi: 10.1016/j.jhep.2015.05.008
16. Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., et al. (2010). Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 24, 2050-2064. doi: 10.1210/me.2010-0142
17. Forner, A., Llovet, J. M., and Bruix, J. (2012). Chemoembolization for intermediate HCC: is there proof of survival benefit? J. Hepatol. 56, 984-986. doi: 10.1016/j.jhep.2011.08.017
18. French, D. M., Lin, B. C., Wang, M., Adams, C., Shek, T., Hötzel, K., et al. (2012). Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. PLoS ONE 7:e36713. doi: 10.1371/journal.pone.0036713
19. Gauglhofer, C., Sagmeister, S., Schrottmaier, W., Fischer, C., Rodgarkia-Dara, C., Mohr, T., et al. (2011). Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis. Hepatology 53, 854-864. doi: 10.1002/hep.24099
20. Giordano, S., and Columbano, A. (2013). MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 57, 840-847. doi: 10.1002/hep.26095
21. Goetz, R., and Mohammadi, M. (2013). Exploring mechanisms of FGF signalling through the lens of structural biology. Nat. Rev. Mol. Cell. Biol. 14, 166-180. doi: 10.1038/nrm3528
22. Guo, L., Degenstein, L., and Fuchs, E. (1996). Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 10, 165-175. doi: 10.1101/gad.10.2.165
23. Habegger, K. M., Stemmer, K., Cheng, C., Müller, T. D., Heppner, K. M., Ottaway, N., et al. (2013). Fibroblast growth factor 21 mediates specific glucagon actions. Diabetes 62, 1453-1463. doi: 10.2337/db12-1116
24. Hanaka, H., Hamada, T., Ito, M., Nakashima, H., Tomita, K., Seki, S., et al. (2014). Fibroblast growth factor-5 participates in the progression of hepatic fibrosis. Exp. Anim. 63, 85-92. doi: 10.1538/expanim.63.85
25. Harimoto, N., Taguchi, K., Shirabe, K., Adachi, E., Sakaguchi, Y., Toh, Y., et al. (2010). The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinoma. Oncology 78, 361-368. doi: 10.1159/000320463
26. Hébert, J. M., Rosenquist, T., Götz, J., and Martin, G. R. (1994). FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell 78, 1017-1025. doi: 10.1016/0092-8674(94)90276-3
27. Holland, W. L., Adams, A. C., Brozinick, J. T., Bui, H. H., Miyauchi, Y., Kusminski, C. M., et al. (2013). An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 17, 790-797. doi: 10.1016/j.cmet.2013.03.019
28. Hotta, Y., Nakamura, H., Konishi, M., Murata, Y., Takagi, H., Matsumura, S., et al. (2009). Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 150, 4625-4633. doi: 10.1210/en.2009-0119
29. Ilagan, R., Abu-Issa, R., Brown, D., Yang, Y. P., Jiao, K., Schwartz, R. J., et al. (2006). Fgf8 is required for anterior heart field development. Development 133, 2435-2445. doi: 10.1242/dev.02408
30. Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., et al. (2005). Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217-225. doi: 10.1016/j.cmet.2005.09.001
31. Itoh, N. (2014). FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases. Front. Endocrinol. 5:107. doi: 10.3389/fendo.2014.00107
32. Kelly, R. G., Brown, N. A., and Buckingham, M. E. (2001). The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev. Cell 1, 435-440. doi: 10.1016/S1534-5807(01)00040-5
33. Kim, S. H., Kim, K. H., Kim, H. K., Kim, M. J., Back, S. H., Konishi, M., et al. (2015). Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia 58, 809-818. doi: 10.1007/s00125-014-3475-6
34. Kir, S., Beddow, S. A., Samuel, V. T., Miller, P., Previs, S. F., Suino-Powell, K., et al. (2011). FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331, 1621-1624. doi: 10.1126/science.1198363
35. Kong, B., Huang, J., Zhu, Y., Li, G., Williams, J., Shen, S., et al. (2014). Fibroblast growth factor 15 deficiency impairs liver regeneration in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G893-G902. doi: 10.1152/ajpgi.00337.2013
36. Kuro-o, M. (2012). Klotho and βKlotho. Adv. Exp. Med. Biol. 728, 25-40. doi: 10.1007/978-1-4614-0887-1_2
37. Li, H., Dong, K., Fang, Q., Hou, X., Zhou, M., Bao, Y., et al. (2013). High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China. J. Hepatol. 58, 557-563. doi: 10.1016/j.jhep.2012.10.029
38. Li, Y., Wong, K., Giles, A., Jiang, J., Lee, J. W., Adams, A. C., et al. (2014). Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology 146, 539.e7-549.e7. doi: 10.1053/j.gastro.2013.10.059
39. Lin, Z., Tian, H., Lam, K. S., Lin, S., Hoo, R. C., Konishi, M., et al. (2013). Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab. 17, 779-789. doi: 10.1016/j.cmet.2013.04.005
40. Liu, J., Xu, Y., Hu, Y., and Wang, G. (2015). The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Metabolism 64, 380-390. doi: 10.1016/j.metabol.2014.11.009
41. Mazza, A., Fruci, B., Garinis, G. A., Giuliano, S., Malaguarnera, R., and Belfiore, A. (2012). The role of metformin in the management of NAFLD. Exp. Diabetes Res. 2012:716404. doi: 10.1155/2012/716404
42. McWhirter, J. R., Goulding, M., Weiner, J. A., Chun, J., and Murre, C. (1997). A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1. Development 124, 3221-3232
43. Miura, S., Mitsuhashi, N., Shimizu, H., Kimura, F., Yoshidome, H., Otsuka, M., et al. (2012). Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma. BMC Cancer 12:56. doi: 10.1186/1471-2407-12-56
44. Murata, Y., Konishi, M., and Itoh, N. (2011). FGF21 as an endocrine regulator in lipid metabolism: from molecular evolution to physiology and pathophysiology. J. Nutr. Metab. 2011:981315. doi: 10.1155/2011/981315
45. Murata, Y., Nishio, K., Mochiyama, T., Konishi, M., Shimada, M., Ohta, H., et al. (2013). Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet. PLoS ONE 8:e69330. doi: 10.1371/journal.pone.0069330
46. Nygaard, E. B., Vienberg, S. G., Ørskov, C., Hansen, H. S., and Andersen, B. (2012). Metformin stimulates FGF21 expression in primary hepatocytes. Exp. Diabetes Res. 2012:465282. doi: 10.1155/2012/465282
47. Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., et al. (2007). BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. U.S.A. 104, 7432-7437. doi: 10.1073/pnas.0701600104
48. Ornitz, D. M., and Itoh, N. (2015). The fibroblast growth factor signaling pathway. Wiley Interdiscip. Rev. Dev. Biol. 4, 215-266. doi: 10.1002/wdev.176
49. Owen, B. M., Ding, X., Morgan, D. A., Coate, K. C., Bookout, A. L., Rahmouni, K., et al. (2014). FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab. 20, 670-677. doi: 10.1016/j.cmet.2014.07.012
50. Potthoff, M. J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., et al. (2009). FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. U.S.A. 106, 10853-10858. doi: 10.1073/pnas.0904187106
51. Qiao, J., Uzzo, R., Obara-Ishihara, T., Degenstein, L., Fuchs, E., and Herzlinger, D. (1999). FGF-7 modulates ureteric bud growth and nephron number in the developing kidney. Development 126, 547-554
52. Qiu, W. H., Zhou, B. S., Chu, P. G., Chen, W. G., Chung, C., Shih, J., et al. (2005). Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma. World J. Gastroenterol. 11, 5266-5272. doi: 10.3748/wjg.v11.i34.5266
53. Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., et al. (2015). Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47, 505-511. doi: 10.1038/ng.3252
54. Sekine, K., Ohuchi, H., Fujiwara, M., Yamasaki, M., Yoshizawa, T., Sato, T., et al. (1999). Fgf10 is essential for limb and lung formation. Nat. Genet. 21, 138-141
55. Shen, J., Chan, H. L., Wong, G. L., Choi, P. C., Chan, A. W., Chan, H. Y., et al. (2012). Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J. Hepatol. 56, 1363-1370. doi: 10.1016/j.jhep.2011.12.025
56. Shen, Y., Ma, X., Zhou, J., Pan, X., Hao, Y., Zhou, M., et al. (2013). Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease. Cardiovasc. Diabetol. 12:124. doi: 10.1186/1475-2840-12-124
57. So, W. Y., Cheng, Q., Xu, A., Lam, K. S., and Leung, P. S. (2015). Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice. Cell Death Dis. 6, e1707. doi: 10.1038/cddis.2015.80
58. Stefan, N., and Häring, H. U. (2013). The role of hepatokines in metabolism. Nat. Rev. Endocrinol. 9, 144-152. doi: 10.1038/nrendo.2012.258
59. Sun, X., Meyers, E. N., Lewandoski, M., and Martin, G. R. (1999). Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev. 13, 1834-1846. doi: 10.1101/gad.13.14.1834
60. Takaki, A., Kawai, D., and Yamamoto, K. (2013). Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int. J. Mol. Sci. 14, 20704-20728. doi: 10.3390/ijms141020704
61. Takase, H. M., Itoh, T., Ino, S., Wang, T., Koji, T., Akira, S., et al. (2013). FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Genes Dev. 27, 169-181. doi: 10.1101/gad.204776.112
62. Tanaka, N., Takahashi, S., Zhang, Y., Krausz, K. W., Smith, P. B., Patterson, A. D., et al. (2015). Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine-and choline-deficient diet. Biochim. Biophys. Acta 1852, 1242-1252. doi: 10.1016/j.bbadis.2015.02.012
63. Taub, R. (2004). Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 5, 836-847. doi: 10.1038/nrm1489
64. Terauchi, A., Johnson-Venkatesh, E. M., Toth, A. B., Javed, D., Sutton, M. A., and Umemori, H. (2010). Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature 465, 783-787. doi: 10.1038/nature09041
65. Tremblay, K. D. (2010). Formation of the murine endoderm: lessons from the mouse, frog, fish, and chick. Prog. Mol. Biol. Transl. Sci. 96, 1-34. doi: 10.1016/B978-0-12-381280-3.00001-4
66. Uriarte, I., Fernandez-Barrena, M. G., Monte, M. J., Latasa, M. U., Chang, H. C., Carotti, S., et al. (2013). Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut 62, 899-910. doi: 10.1136/gutjnl-2012-302945
67. Uriarte, I., Latasa, M. U., Carotti, S., Fernandez-Barrena, M. G., Garcia-Irigoyen, O., Elizalde, M., et al. (2015). Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development. Int. J. Cancer 136, 2469-2475. doi: 10.1002/ijc.29287
68. van Zijl, F., Zulehner, G., Petz, M., Schneller, D., Kornauth, C., Hau, M., et al. (2009). Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol. 5, 1169-1179. doi: 10.2217/fon.09.91
69. Vincentz, J. W., McWhirter, J. R., Murre, C., Baldini, A., and Furuta, Y. (2005). Fgf15 is required for proper morphogenesis of the mouse cardiac outflow tract. Genesis 41, 192-201. doi: 10.1002/gene.20114
70. Wang, J., Rhee, S., Palaria, A., and Tremblay, K. D. (2015). FGF signaling is required for anterior but not posterior specification of the murine liver bud. Dev. Dyn. 244, 431-443. doi: 10.1002/dvdy.24215
71. Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., et al. (2009). Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250-259. doi: 10.2337/db08-0392
72. Yang, H., Fang, F., Chang, R., and Yang, L. (2013). MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology 58, 205-217. doi: 10.1002/hep.26315
73. Yilmaz, Y., and Eren, F. (2012). Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. Clin. Chim. 414, 154-157. doi: 10.1016/j.cca.2012.08.005
74. Zhao, H., Lv, F., Liang, G., Huang, X., Wu, G., Zhang, W., et al. (2015). FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β-catenin signaling cascade via FGFR4 activation. Oncotarget 7, 13575-13586. doi: 10.1186/1471-2407-12-56